The Use of Angiogenic and Hypoxia Biomarkers to Predict the Benefit from Dose Escalation Using External Beam Radiotherapy Plus a High Dose-Rate Brachytherapy Boost Compared to External Beam Radiotherapy Alone in Localized Prostate Cancer
Keyword(s):
2010 ◽
Vol 78
(3)
◽
pp. S374
2012 ◽
Vol 103
(2)
◽
pp. 217-222
◽
2019 ◽
Vol 132
◽
pp. 162-170
◽
2017 ◽
Vol 5
◽
pp. 393-402
◽
2018 ◽
Vol 25
(4)
◽
pp. 366-371
◽